Drug has already been approved in the EU and Japan
Topline results published from CheckMate-649 and CheckMate-577 studies
Deal will include access to investigational menopause drug
Updated Date: Tue, 04 Aug 2020 00:00:00 EDT
Updated Date: Tue, 04 Aug 2020 00:00:00 EDT
AstraZeneca bumps up vaccine deal with Brazil to $360M with more doses, licensing rights kblankenship Tue, 08/11/2020 – […]
Coronavirus tracker: Novavax boasts billion-plus shot capacity by 2021; Russia’s world-first nod for COVID-19 vaccine sparks concern fkansteiner […]
New research into malaria suggests targeting enzymes from the human host, rather than from the pathogen itself, could […]
Higher continuity of care is associated with lower mortality rates, while discontinuity can cause patients to feel as […]
